Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 4,053 INR
Change Today 0.00 / 0.00%
Volume 0.0
DRRD On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
As of 7:05 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for dr. reddy's laboratories (DRRD)

Year over year, Dr. Reddy's Laboratories Ltd. has been able to grow revenues from 131.4B INR to 147.4B INR. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 29.90% to 28.55%. This was a driver that led to a bottom line growth from 21.5B INR to 22.2B INR.
View Income Statement In U.S. Dollar
Currency in
Millions of Indian Rupees
As of:Mar 31
2012
Restated
INR
Mar 31
2013
Reclassified
INR
Mar 31
2014
INR
Mar 31
2015
INR
4 Year
Trend
Revenues96,332.0115,548.0131,350.0147,360.0
TOTAL REVENUES96,332.0115,548.0131,350.0147,360.0
Cost of Goods Sold43,027.054,969.055,549.061,957.0
GROSS PROFIT53,305.060,579.075,801.085,403.0
Selling General & Admin Expenses, Total28,867.033,584.039,280.042,076.0
R&D Expenses5,911.07,782.012,402.017,329.0
Other Operating Expenses-784.0-1,056.0-948.0-1,061.0
OTHER OPERATING EXPENSES, TOTAL33,994.040,310.050,734.058,344.0
OPERATING INCOME19,311.020,269.025,067.027,059.0
Interest Expense-1,067.0-1,018.0-1,274.0-1,092.0
Interest and Investment Income538.01,113.01,089.01,061.0
NET INTEREST EXPENSE-529.095.0-185.0-31.0
Income (Loss) on Equity Investments54.0104.0174.0195.0
Currency Exchange Gains (Loss)689.0365.0372.0115.0
EBT, EXCLUDING UNUSUAL ITEMS19,525.020,833.025,428.027,338.0
Impairment of Goodwill---181.0----
Gain (Loss) on Sale of Investments----213.0755.0
Gain (Loss) on Sale of Assets-9.0143.053.0-144.0
Other Unusual Items, Total-1,050.0881.0912.0214.0
Legal Settlements-10.01,388.0415.0--
Other Unusual Items------843.0
EBT, INCLUDING UNUSUAL ITEMS18,466.021,676.026,606.028,163.0
Income Tax Expense4,204.04,900.05,094.05,984.0
Minority Interest in Earnings--1.03.0--
Earnings from Continuing Operations14,262.016,776.021,512.022,179.0
NET INCOME14,262.016,777.021,515.022,179.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS14,262.016,777.021,515.022,179.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS14,262.016,777.021,515.022,179.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DRRD:IN 4,052.85 INR -156.35

DRRD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aurobindo Pharma Ltd 723.05 INR 0.00
Croda International PLC 2,799 GBp -57.00
Endo International PLC $73.00 USD -1.46
Sigma-Aldrich Corp $139.46 USD -0.10
Symrise AG €52.41 EUR -0.80
View Industry Companies
 

Industry Analysis

DRRD

Industry Average

Valuation DRRD Industry Range
Price/Earnings 30.2x
Price/Sales 4.6x
Price/Book 5.8x
Price/Cash Flow 30.1x
TEV/Sales 4.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DR. REDDY'S LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.